Respiri - wheezo included in paediatric standard of care
Respiri has announced the successful completion of the Michigan Children’s Hospital’s pilot programme assessing the wheezo SAAS (Respiri and...
208 Views
Respiri - Dollars in the bank with CMS reimbursement
In a positive development for its US commercial strategy, Respiri has announced receipt of its first reimbursement claims from the Centers for...
250 Views
Respiri - Trading recap highlights continued market traction
Respiri has released its Q223 quarterly activity report and provided a business update for the quarter. The second quarter was characterised by...
313 Views
Respiri - NC rollout to expand wheezo market potential
Respiri has started patient onboarding for a major North Carolina (NC)-based healthcare organisation (the initial contract was signed in August...
480 Views
Respiri - New funding to support commercial traction
Respiri has announced a A$1.5m capital raise through a security purchase plan (SPP) to existing shareholders (up to 30m shares to be issued at...
673 Views